Biotech investor Robert Nelsen predicted at a live recording of STAT’s “Readout LOUD” podcast last month in San Francisco that artificial intelligence will ultimately replace doctors, asserting that AI is already superior to “most of [his] doctors.” The controversial statement, made during a J.P. Morgan Healthcare Conference event, sparked debate online, but Nelsen reaffirmed his position on X.
Nelsen’s forecast coincides with increasing exploration of AI’s role in healthcare, including automating tasks traditionally performed by physicians. Doctronic, a startup, is developing an AI system designed to renew prescriptions. Utah has taken the step of allowing Doctronic’s chatbot to do so, enacting a waiver of some state regulations governing the practice of medicine.
The functionality and regulatory implications of Doctronic’s “AI Doctor” were discussed on a recent episode of STAT’s “STATus Report.” Host Alex Hogan interviewed STAT health tech reporter Mario Aguilar about the chatbot’s operation, the argument that it falls outside the Food and Drug Administration’s regulatory purview, and the concerns raised by some medical experts.
The “Readout LOUD” podcast, featuring Nelsen and Novo Nordisk CEO Mike Doustdar, was a live taping from the J.P. Morgan Healthcare Conference (#JPM26). The event, hosted by STAT, drew attention to the intersection of biotechnology, venture capital, and emerging technologies like AI. The podcast is a regular feature of STAT, offering insights into the healthcare industry.
The discussion surrounding AI and healthcare comes as the industry grapples with the potential for technological disruption. The implications of AI-driven prescription renewals, and the regulatory challenges they present, remain a subject of ongoing debate.
